Enhanced Expression of miR-181b in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response

SIMPLE SUMMARY: Low expression of miR-181b in chronic lymphocytic leukemia (CLL) is linked to progression and cell death resistance. Patients with the progression of the disease show immune dysfunction. We aim at studying whether miR-181b is also involved in this process. We demonstrate that miR-181...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Marco, Mirco, Veschi, Serena, Lanuti, Paola, Ramassone, Alice, Pacillo, Stefania, Pagotto, Sara, Pepe, Felice, George-William, Jonahunnatha Nesson, Curcio, Claudia, Marchisio, Marco, Miscia, Sebastiano, Innocenti, Idanna, Autore, Francesco, Vannata, Barbara, Di Gregorio, Patrizia, Di Gioacchino, Mario, Valentinuzzi, Silvia, Iezzi, Manuela, Mariani-Costantini, Renato, Larocca, Luigi Maria, Laurenti, Luca, Veronese, Angelo, Visone, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826592/
https://www.ncbi.nlm.nih.gov/pubmed/33445508
http://dx.doi.org/10.3390/cancers13020257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826592/
https://www.ncbi.nlm.nih.gov/pubmed/33445508
http://dx.doi.org/10.3390/cancers13020257

Ejemplares similares